H. Han, E. Hamilton, H. Irie, S. Isakoff, D. Jelovac, A. Liem, Minetta C. Liu, A. Milillo, J. Nangia, D. Page, J. Reeves, C. Santa-Maria, M. Duncan, J. Graham, J. Chen, B. Dezube, Laura M. Spring
{"title":"摘要:开放标签、单臂研究评估尼拉帕尼作为局部her2阴性brca突变型乳腺癌患者新辅助治疗的抗肿瘤活性和安全性","authors":"H. Han, E. Hamilton, H. Irie, S. Isakoff, D. Jelovac, A. Liem, Minetta C. Liu, A. Milillo, J. Nangia, D. Page, J. Reeves, C. Santa-Maria, M. Duncan, J. Graham, J. Chen, B. Dezube, Laura M. Spring","doi":"10.1158/1538-7445.SABCS18-OT3-03-01","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19476,"journal":{"name":"Ongoing Clinical Trials","volume":"11 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract OT3-03-01: Open-label, single-arm study evaluating the antitumor activity and safety of niraparib as neoadjuvant treatment in patients with localized,HER2-negative,BRCA-mutant breast cancer\",\"authors\":\"H. Han, E. Hamilton, H. Irie, S. Isakoff, D. Jelovac, A. Liem, Minetta C. Liu, A. Milillo, J. Nangia, D. Page, J. Reeves, C. Santa-Maria, M. Duncan, J. Graham, J. Chen, B. Dezube, Laura M. Spring\",\"doi\":\"10.1158/1538-7445.SABCS18-OT3-03-01\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":19476,\"journal\":{\"name\":\"Ongoing Clinical Trials\",\"volume\":\"11 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ongoing Clinical Trials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.SABCS18-OT3-03-01\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ongoing Clinical Trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.SABCS18-OT3-03-01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Abstract OT3-03-01: Open-label, single-arm study evaluating the antitumor activity and safety of niraparib as neoadjuvant treatment in patients with localized,HER2-negative,BRCA-mutant breast cancer